Clinical Consultations™ Integrating Modern Antipsychotic Medications into the Management of Patients with Schizophrenia

Activity Overview
Schizophrenia is a common psychiatric disorder with a significant long-term disease burden considered greater than that associated with any other mental illness. It is one of the most stigmatized psychiatric illnesses. Use of atypical antipsychotic medications is effective for many patients, yet relapse is common and often due to medication nonadherence. Main among the myriad of reasons underlying nonadherence are adverse effects that include weight gain and sedation and patient concerns about safety. As such, development of many new agents is aimed at addressing these adverse effects. This educational activity features expert faculty who highlight the illness burden, share clinically relevant aspects of nonadherence and resultant relapse, and examine key data on new and emerging agents aimed at overcoming treatment challenges.
Target Audience
This educational activity is directed toward psychiatrists and other health care professionals involved in the management of patients with schizophrenia.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
• Describe the unmet needs in the treatment of patients with schizophrenia
• Evaluate clinical trial data for new and emerging agents for the treatment of patients with schizophrenia
• Formulate individualized treatment plans for patients with schizophrenia